ClinConnect ClinConnect Logo
Search / Trial NCT06837779

Exposed Hypersensitive Dentin Treated With Fluoride Iontophoresis With Remineralizing Agents

Launched by AL-AZHAR UNIVERSITY · Feb 19, 2025

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Hypersinsitivity Flouride Iontophoresis

ClinConnect Summary

Assess the efficacy of fluoride iontophoresis in remineralization in comparison with other ingredients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients within 35-60 years of age.
  • Each patient has 4 or more exposed roots of posterior teeth having sensitivity.
  • Good oral hygiene.
  • Patients who will agree to the consent and will commit to the follow-up period.
  • Patients will follow instructions during study time.
  • Teeth that were vital.
  • Exclusion Criteria:
  • Patients with any systemic disease that may affect normal healing.
  • Patient with bad oral hygiene, high caries index and high plaque index
  • Patients participating in more than 1 dental study.
  • Active carious lesions.
  • Intrinsic and extrinsic stains.
  • Any previous filling of selected teeth.
  • Cracked and malformed teeth.

About Al Azhar University

Al-Azhar University, a prestigious institution in Egypt, is dedicated to advancing medical research and education through rigorous clinical trials. With a strong emphasis on ethical standards and scientific integrity, the university aims to contribute to the development of innovative therapies and healthcare solutions. By fostering collaboration among researchers, healthcare professionals, and academic experts, Al-Azhar University positions itself as a leading sponsor in clinical research, committed to improving patient outcomes and enhancing the understanding of various medical conditions.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Trial Officials

Mohamed Wakwak, A

Principal Investigator

Alazhar Univeristy

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported